Clinical Trials Logo

Essential Hypertension clinical trials

View clinical trials related to Essential Hypertension.

Filter by:

NCT ID: NCT01413048 Recruiting - Clinical trials for Essential Hypertension

Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension

Start date: January 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the antihypertensive effect of AGSCT101 tablet in patient with stage 1 to 2 essential hypertension.

NCT ID: NCT01373086 Terminated - Hypertension Clinical Trials

LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension

Start date: May 2011
Phase: Phase 2
Study type: Interventional

This study will assess the efficacy and safety of LFF269 compared to placebo after treatment in subjects with essential hypertension.

NCT ID: NCT01342614 Completed - Diabetes Mellitus Clinical Trials

The Effect of Metformin on the Correlation Between Hyperinsulinemia and Hypertension

Start date: May 2006
Phase: N/A
Study type: Interventional

The objective of this study is to investigate the effect of metformin on the correlation between hyperinsulinemia and hypertension.

NCT ID: NCT01320397 Not yet recruiting - Clinical trials for Essential Hypertension

Antihypertensive Effect of Rostafuroxin Compared With Losartan in Hypertensive Patients Bearing Specified Gene Mutations

Start date: May 2011
Phase: Phase 2
Study type: Interventional

The principal aim of the study is to demonstrate that Rostafuroxin is able to induce a more pronounced reduction of arterial blood pressure respect to Losartan, in hypertensive patients carrying at least one of the pre-specified gene mutations. In previous studies has been demonstrated that these mutations are able to induce specific alterations inducing an increase of sodium (Na) reabsorption at renal tubular level and an increase of arterial blood pressure. Pilot studies have demonstrated that Rostafuroxin is able to reduce the impact of these alterations, and so directly reverse the increase in blood pressure.

NCT ID: NCT01307046 Completed - Hypertension Clinical Trials

MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352)

Start date: March 29, 2011
Phase: Phase 3
Study type: Interventional

This study is being conducted to evaluate the efficacy of MK-0954A in essential hypertension participants who are not adequately controlled with losartan.

NCT ID: NCT01307033 Completed - Hypertension Clinical Trials

A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)

Start date: March 29, 2011
Phase: Phase 3
Study type: Interventional

This study is being conducted to evaluate the safety of MK-0954A (L100/H12.5 mg) in essential hypertension participants who are uncontrolled with MK-954H (L50/H12.5 mg).

NCT ID: NCT01302691 Completed - Hypertension Clinical Trials

MK-0954E Study in Participants With Hypertension (MK-0954E-357)

Start date: January 1, 2011
Phase: Phase 3
Study type: Interventional

This study is being done to evaluate the efficacy, safety, and tolerability of losartan potassium 50 mg (L50) + hydrochlorothiazide 12.5 mg (H12.5) + amlodipine besylate 5 mg (A5) (MK-0954E). The primary hypothesis is that L50/H12.5/A5 is more effective in lowering mean trough sitting diastolic blood pressure (SiDBP) after 8 weeks of treatment compared to L50+A5 in Japanese participants with essential hypertension who are not adequately controlled following an 8-week treatment with filter period study drug (L50+A5).

NCT ID: NCT01295021 Completed - Clinical trials for Essential Hypertension

The Prevalence of Sympathetic Overactivity in Primary Hypertensive Patients.

SORT
Start date: February 2011
Phase: N/A
Study type: Observational

The purpose of this NIS is to assess the prevalence of sympathetic overactivity in patients with newly diagnosed essential hypertension.

NCT ID: NCT01289899 Completed - Clinical trials for Essential Hypertension

Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects

Start date: January 2004
Phase: Phase 1
Study type: Interventional

The objective of this study is to determine the safety and tolerability and to determine the Pharmacokinetic and Pharmacodynamic(PK/PD) of ascending multiple oral dose of BR-A-657 in healthy male subjects.

NCT ID: NCT01289886 Completed - Clinical trials for Essential Hypertension

Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects

Start date: September 2003
Phase: Phase 1
Study type: Interventional

The objective of this study is to determine the safety and tolerability and to determine the Pharmacokinetic and Pharmacodynamic (PK/PD) of ascending single oral dose of BR-A-657 in healthy male subjects.